SCHEMBL23517879

SCHEMBL23517879

c1ccc(-c2nc(-c3ccc4c(c3)oc3ccccc34)nc(-c3cc(-c4ccc5c6ccccc6c6ccccc6c5c4)c4c(c3)oc3ccccc34)n2)cc1

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
AHR P35869 2/20 0.37
MAPT P10636 6/20 0.36
KMT2A Q03164 4/20 0.36
ALDH1A1 P00352 4/20 0.36
MEN1 O00255 3/20 0.36
HPGD P15428 3/20 0.36
KDM4E B2RXH2 2/20 0.36
HCRTR1 O43613 1/20 0.35
TTR P02766 1/20 0.35
MMP12 P39900 1/20 0.34
MMP13 P45452 1/20 0.34
POLB P06746 2/20 0.34
TSHR P16473 2/20 0.34
LMNA P02545 1/20 0.34
HTT P42858 1/20 0.34
PLA2G2A P14555 1/20 0.33
PLA2G4A P47712 1/20 0.33
ALOX5 P09917 1/20 0.33
CHEK2 O96017 1/20 0.33
PTGER4 P35408 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23312777 0.97 MAPT (0.35) AHRMAPTKMT2AALDH1A1MEN1
SCHEMBL23517489 0.96 PLA2G2A (0.36) MAPTKMT2AALDH1A1MEN1HPGD
SCHEMBL23312698 0.96 PLA2G2A (0.36) MAPTKMT2AALDH1A1MEN1HPGD
SCHEMBL27391433 0.96 AHR (0.40) AHRMAPTKMT2AALDH1A1MEN1
SCHEMBL24066147 0.95 AHR (0.39) AHRMAPTKMT2AALDH1A1MEN1
SCHEMBL25458645 0.95 AHR (0.39) AHRMAPTKMT2AALDH1A1MEN1
SCHEMBL23312642 0.95 MAPT (0.37) MAPTKMT2AALDH1A1MEN1HPGD
SCHEMBL23312520 0.94 PLA2G2A (0.39) MAPTKMT2AALDH1A1MEN1HPGD
SCHEMBL23517507 0.94 PLA2G2A (0.39) MAPTKMT2AALDH1A1MEN1HPGD
SCHEMBL27278498 0.94 PLA2G2A (0.36) MAPTKMT2AALDH1A1MEN1HPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-12018022-B2 Heterocyclic compound, organic light emitting diode comprising same, composition for organic layer of organic light emitting diode, and method for manufacturing organic light emitting diode LT MATERIALS CO., LTD. (KR) 2024-06-25 US disclosed
US-20210179596-A1 HETEROCYCLIC COMPOUND, ORGANIC LIGHT EMITTING DIODE COMPRISING SAME, COMPOSITION FOR ORGANIC LAYER OF ORGANIC LIGHT EMITTING DIODE, AND METHOD FOR MANUFACTURING ORGANIC LIGHT EMITTING DIODE LT MATERIALS CO., LTD. (KR) 2021-06-17 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-12018022-B2 Heterocyclic compound, organic light emitting diode comprising same, composition for organic layer of organic light emitting diode, and method for manufacturing organic light emitting diode ODC1, AOX1, CYP1B1 AHR 105/4885MAPT 1022/4885KMT2A 1383/4885
US-20210179596-A1 HETEROCYCLIC COMPOUND, ORGANIC LIGHT EMITTING DIODE COMPRISING SAME, COMPOSITION FOR ORGANIC LAYER OF ORGANIC LIGHT EMITTING DIODE, AND METHOD FOR MANUFACTURING ORGANIC LIGHT EMITTING DIODE ODC1, AOX1, CYP1B1 AHR 105/4885MAPT 1022/4885KMT2A 1383/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.